Entrepreneurial companies take all shapes and forms. Some offer a brand new service or product to the market; others improve or refine a traditional process that’s been in place for many years. The latter is exactly what London-based Critical Outcome Technologies Inc. (COTI) sets out to do.

Dr. Wayne Danter started COTI ten years ago while still an associate professor of medicine. Through a postgraduate research fellowship, he had a first-hand look into pharmacological processes and procedures; this in turn was what eventually drove COTI’s development. “I saw an inefficient use of time and money in the pharmaceutical industry, and knew that there had to be a better way to get effective drug therapies to their crucial testing phase, and eventually out into the market.”

Click here to read the December edition of Business London Magazine. This month's TechAlliance article (on page 18) highlights COTI's innovative drug discovery process and how a part-time endeavour for the company's founder turned into a world-class company recognized for its ability to reduce drug development timelines.